心臟辅助设备市场规模、份额和成长分析（按产品类型、部位、模式和地区划分）－2026-2033年产业预测

全球心臟辅助设备市场规模预计在 2024 年达到 42.5 亿美元，从 2025 年的 48.3 亿美元增长到 2033 年的 135 亿美元，在预测期（2026-2033 年）内复合年增长率为 13.7%。

全球心臟辅助设备市场涵盖用于支援或取代心臟功能、维持心臟衰竭或心臟病患者正常血液循环的医疗设备。这些设备对于治疗末期心臟衰竭、心源性休克、心血管手术后復健以及等待或不适合心臟移植的患者至关重要。心血管疾病盛行率的上升、人口老化以及技术进步是推动市场成长的主要因素。小型化、耐用性和电池寿命方面的创新提高了设备的效率和易用性，而微创植入技术则扩大了患者的覆盖范围。在成熟企业和新兴企业竞争激烈的市场环境中，持续的研究与合作对于推动市场发展和改善患者照护效果至关重要。

全球心臟辅助设备市场驱动因素

心血管疾病，尤其是冠状动脉疾病的日益流行，是全球心臟辅助设备市场的主要驱动力。不健康的饮食习惯、久坐的生活方式以及生活方式的整体改变等因素，正在推动全球范围内此类疾病的发病率上升。随着越来越多的人面临心血管健康方面的挑战，对创新心臟辅助技术的需求持续成长。这一趋势凸显了为心臟疾病患者提供有效解决方案的迫切需求，从而推动了心臟辅助设备领域的进一步发展和投资。

限制全球心臟辅助设备市场的因素

全球心臟辅助设备市场面临许多限制因素，这些限制因素源自于这些复杂系统固有的各种技术挑战。设备的正确植入、管理和持续监测需要高技能人员和专门的基础设施，而并非所有医疗机构都具备这些条件。这种技术复杂性，加上医疗专业人员学习曲线陡峭，可能会阻碍心臟辅助技术的广泛应用。因此，由于医疗机构难以获得足够的培训和资源来有效利用这些关键设备，市场成长潜力可能受到限制。

全球心臟辅助设备市场趋势

全球心臟辅助设备市场正呈现以患者为中心的设计趋势，强调改善心臟病患者的使用者体验和生活品质。製造商越来越重视舒适性和便携性，这推动了更小巧、更安静、植入併发症更少的设备的发展。这种设计理念不仅满足了患者的需求，也促进了创新，促使企业致力于研发能够无缝融入日常生活的设备。随着人们对患者偏好的认识不断提高，预计市场将朝着更有效、更人性化的心臟辅助解决方案方向发展。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球心臟辅助设备市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 经人工心臟（TAH）
• 主动脉内球囊反搏帮浦（IABP）
• 心室辅助装置（VAD）

全球心臟辅助设备市场规模（按安装地点和复合年增长率划分）（2026-2033 年）

• 右心室辅助装置（RVAD）
• 左心室辅助装置（LVAD）
• 体外心室辅助装置（VAD）
• 双心室辅助装置（Bi-VAD）

全球心臟辅助设备市场规模（按模式类型和复合年增长率划分）（2026-2033 年）

• 经皮
• 可植入式

全球心臟辅助设备市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 其他的

全球心臟辅助设备市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Berlin Heart GmbH（Germany）
• Biotronik SE & Co. KG（Germany）
• ReliantHeart Inc.（United States）
• SynCardia Systems, LLC（United States）
• Teleflex Incorporated（United States）
• Levitronix GmbH（Switzerland）
• Jarvik Heart, Inc.（United States）
• Sunshine Heart, Inc.（United States）
• CardiacAssist, Inc.（TandemLife）（United States）
• CorWave SA（France）
• Evaheart, Inc.（Japan）
• FineHeart SA（France）
• Windmill Cardiovascular Systems, Inc.（United States）
• CARMAT（France）
• Calon Cardio-Technology Ltd.（United Kingdom）
• NewHeart Medical Devices, LLC（United States）
• MiTiHeart Corporation（United States）
• CircuLite, Inc.（United States）
• CardioBridge GmbH（Germany）

结论与建议

Global Cardiac Assist Devices Market size was valued at USD 4.25 Billion in 2024 and is poised to grow from USD 4.83 Billion in 2025 to USD 13.5 Billion by 2033, growing at a CAGR of 13.7% during the forecast period (2026-2033).

The global Cardiac Assist Devices market encompasses medical equipment engineered to support individuals facing heart failure or cardiac issues by assisting or replacing heart function to maintain proper blood circulation. These devices are vital for managing conditions such as end-stage heart failure, cardiogenic shock, and recovery post-cardiac surgery. They cater to patients awaiting heart transplants or those unsuitable for such procedures. The market's growth is bolstered by the rising prevalence of cardiovascular diseases, an aging population, and advancements in technology. Innovations in miniaturization, durability, and battery life boost efficiency and user-friendliness, while minimally invasive implantation techniques broaden patient eligibility. With a competitive landscape of established and emerging players, ongoing research and collaborations are essential for market evolution and improved patient care outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Assist Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Assist Devices Market Segments Analysis

Global Cardiac Assist Devices Market is segmented by Product Type, Placement Location, Modality Type, End User and region. Based on Product Type, the market is segmented into Total Artificial Heart (TAH), Intra-Aortic Balloon Pumps (IABP) and Ventricular Assist Devices (VAD). Based on Placement Location, the market is segmented into Right Ventricular Assist Device (RVAD), Left Ventricular Assist Device (LVAD), External Ventricular Assist Device (VAD) and Bi-Ventricular Assist Device (Bi-VAD). Based on Modality Type, the market is segmented into Transcutaneous and Implantable. Based on End User, the market is segmented into Hospital, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Assist Devices Market

The increasing prevalence of cardiovascular diseases, particularly coronary artery disease, significantly propels the global Cardiac Assist Devices market. Factors such as unhealthy dietary habits, sedentary lifestyles, and overall lifestyle changes have led to a heightened incidence of these conditions worldwide. As more individuals face the challenges associated with cardiovascular health, the demand for innovative cardiac assist technologies continues to grow. This trend underscores the need for effective solutions to assist patients suffering from heart-related ailments, thereby further stimulating advancements and investments within the cardiac assist devices sector.

Restraints in the Global Cardiac Assist Devices Market

The Global Cardiac Assist Devices market faces significant constraints due to various technical challenges inherent in these advanced systems. Proper implantation, management, and ongoing monitoring of the devices demand a highly skilled workforce and specialized infrastructure, which may not be readily available in all healthcare settings. These technical complexities, combined with steep learning curves for healthcare providers, can hinder the widespread adoption of cardiac assist technologies. As a result, the market's growth potential could be limited, as healthcare institutions grapple with ensuring adequate training and resources to effectively utilize these critical devices.

Market Trends of the Global Cardiac Assist Devices Market

The Global Cardiac Assist Devices market is witnessing a significant trend towards patient-centric design, emphasizing the enhancement of user experience and quality of life for individuals with cardiac conditions. Manufacturers are increasingly prioritizing comfort and portability, leading to the development of smaller, quieter devices that minimize complications during implantation. This focus on design not only caters to patient needs but also drives innovation, as companies seek to create devices that integrate seamlessly into daily life. As awareness of patient preferences continues to grow, the market is likely to evolve in favor of more effective and user-friendly cardiac assist solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Cardiac Assist Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Total Artificial Heart (TAH)
• Intra-Aortic Balloon Pumps (IABP)
• Ventricular Assist Devices (VAD)

Global Cardiac Assist Devices Market Size by Placement Location & CAGR (2026-2033)

• Market Overview
• Right Ventricular Assist Device (RVAD)
• Left Ventricular Assist Device (LVAD)
• External Ventricular Assist Device (VAD)
• Bi-Ventricular Assist Device (Bi-VAD)

Global Cardiac Assist Devices Market Size by Modality Type & CAGR (2026-2033)

• Market Overview
• Transcutaneous
• Implantable

Global Cardiac Assist Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospital
• Ambulatory Surgical Centers
• Others

Global Cardiac Assist Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Placement Location, Modality Type, End User)
  • US
  • Canada
• Europe (Product Type, Placement Location, Modality Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Placement Location, Modality Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Placement Location, Modality Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Placement Location, Modality Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReliantHeart Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Levitronix GmbH (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sunshine Heart, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardiacAssist, Inc. (TandemLife) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorWave SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evaheart, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FineHeart SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Windmill Cardiovascular Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARMAT (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Calon Cardio-Technology Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NewHeart Medical Devices, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiTiHeart Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CircuLite, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioBridge GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations